ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹-446 Cr | ₹-649 Cr | ₹-688 Cr | ₹-893 Cr | ₹-751 Cr |
What is the latest Total Non-Current Liabilities ratio of ALKEM LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹-446 Cr |
| Mar2024 | ₹-649 Cr |
| Mar2023 | ₹-688 Cr |
| Mar2022 | ₹-893 Cr |
| Mar2021 | ₹-751 Cr |
How is Total Non-Current Liabilities of ALKEM LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-446 Cr | Negative | |
| Mar2024 | ₹-649 Cr | Negative | |
| Mar2023 | ₹-688 Cr | Negative | |
| Mar2022 | ₹-893 Cr | Negative | |
| Mar2021 | ₹-751 Cr | - | |
Compare Total Non-Current Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹62,874.9 Cr | -1.1% | -8.9% | 5.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -1.4% | -3.2% | -0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -1.9% | -8.7% | 1.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -3.5% | -6.6% | 30.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -4% | -8.3% | 6.3% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -1.9% | -11.9% | -19% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -1.1% |
-8.9% |
5.6% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses